Literature DB >> 2784485

Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

T Takeshita1, Y Goto, K Tada, K Nagata, H Asao, K Sugamura.   

Abstract

A mouse hybridoma cell line, TU27, producing an mAb was established. TU27 mAb reacted with various human and Gibbon ape T cell lines bearing the IL-2R p75 (IL-2Rp75), but not with cell lines expressing only Tac antigen, IL-2Rp55, and numbers of its binding sites on cell surfaces were similar to those of high-affinity IL-2R. Radioimmunoprecipitation with TU27 mAb defined a molecule with a molecular mass of 75 kD on the surface of IL-2Rp75 bearing cells. TU27 mAb completely blocked IL-2 binding to IL-2Rp75 and to the high-affinity IL-2R but not to IL-2Rp55 composing the low-affinity IL-2R. The IL-2-dependent growth of a human T cell line, ILT-Mat, was significantly inhibited by TU27 mAb only at low concentrations of IL-2, and combination of TU27 mAb and H-31 mAb specific for IL-2Rp55 completely inhibited the cell growth even at high concentrations of IL-2. These data strongly suggest that TU27 mAb is specific for the human IL-2Rp75.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784485      PMCID: PMC2189229          DOI: 10.1084/jem.169.4.1323

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Reconstitution of a functional interleukin 2 receptor in a nonlymphoid cell.

Authors:  L A Rubin; G S Hoekzema; D L Nelson; W C Greene; G Jay
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

2.  Protein phosphorylation mediated by IL-2/IL-2 receptor beta-chain interaction.

Authors:  T Ishii; T Takeshita; N Numata; K Sugamura
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  Identification of a glycoprotein, gp21, of adult T cell leukemia virus by monoclonal antibody.

Authors:  K Sugamura; M Fujii; S Ueda; Y Hinuma
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

5.  Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.

Authors:  K Sugamura; M Fujii; M Kannagi; M Sakitani; M Takeuchi; Y Hinuma
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

6.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

7.  Molecular cloning of cDNA encoding human interleukin-2 receptor.

Authors:  T Nikaido; A Shimizu; N Ishida; H Sabe; K Teshigawara; M Maeda; T Uchiyama; J Yodoi; T Honjo
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

8.  Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan.

Authors:  S Kashiwagi; J Hayashi; H Ikematsu; A Noguchi; K Ikeda; K Kishida; M Shirakawa; A Takenaka; R Mori
Journal:  Microbiol Immunol       Date:  1988       Impact factor: 1.955

9.  Novel receptor-mediated internalization of interleukin 2 in B cells.

Authors:  T Tanaka; O Saiki; S Doi; M Fuji; K Sugamura; H Hara; S Negoro; S Kishimoto
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  58 in total

Review 1.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines.

Authors:  Zulmarie Perez Horta; Swetha Saseedhar; Alexander L Rakhmilevich; Lakeesha Carmichael; Jacquelyn A Hank; Margaret Boyden; Stephen D Gillies; Paul M Sondel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

Review 3.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

4.  Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.

Authors:  R A Janssen; A A Heijn; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

5.  Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Authors:  S D Voss; T P Leary; P M Sondel; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

6.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

7.  The IL-2 receptor beta subunit is absolutely required for mediating the IL-2-induced activation of NK activity and proliferative activity of human large granular lymphocytes.

Authors:  H Umehara; E T Bloom
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

8.  Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.

Authors:  N Kobayashi; T Kono; M Hatakeyama; Y Minami; T Miyazaki; R M Perlmutter; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.

Authors:  E A Grimm; J M Bruner; J Carinhas; J A Köppen; W G Loudon; L Owen-Schaub; P A Steck; R P Moser
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.

Authors:  A J Grant; E Roessler; G Ju; M Tsudo; K Sugamura; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.